IC

Verona Pharma plc (VRNA)

NASDAQ: VRNA · Real-Time Price · USD

67.57

+0.04 (0.06%)

May 13, 2025, 4:00 PM - Market closed

Verona Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	May '25 May 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	6,159	3,800	1,709	2,133	444	405	Upgrade
Market Cap Growth	314.06%	122.40%	-19.89%	380.79%	9.47%	435.09%	Upgrade
Enterprise Value	6,001	3,587	1,472	1,907	283	205	Upgrade
Last Close Price	67.57	46.44	19.88	26.13	6.72	7.00	Upgrade
PS Ratio	47.08	89.89	-	4657.40	11.09	-	Upgrade
PB Ratio	27.18	18.58	6.85	9.26	3.00	2.19	Upgrade
P/TBV Ratio	27.24	18.63	6.87	9.28	3.01	2.20	Upgrade
EV/Sales Ratio	50.63	84.83	-	4164.23	7.09	-	Upgrade
Debt / Equity Ratio	1.08	1.12	0.21	0.05	0.04	0.03	Upgrade
Asset Turnover	0.29	0.11	-	0.00	0.21	-	Upgrade
Quick Ratio	8.30	10.24	32.53	12.46	4.91	13.82	Upgrade
Current Ratio	8.86	10.63	33.33	12.77	5.09	14.26	Upgrade
Return on Equity (ROE)	-72.61%	-76.42%	-22.67%	-36.30%	-33.39%	-57.25%	Upgrade
Return on Assets (ROA)	-20.64%	-24.13%	-14.64%	-18.53%	-18.45%	-31.68%	Upgrade
Return on Capital (ROIC)	-22.55%	-25.72%	-15.34%	-20.93%	-20.92%	-35.14%	Upgrade
Earnings Yield	-2.66%	-4.56%	-3.18%	-3.22%	-12.53%	-16.07%	Upgrade
FCF Yield	-1.97%	-3.23%	-2.94%	-2.81%	-7.50%	-11.14%	Upgrade
Buyback Yield / Dilution	-3.21%	-2.86%	-19.86%	-11.81%	-79.97%	-149.64%	Upgrade

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q